ONEOK Q3 2026: EBITDA +6% YoY, Third Guidance Raise

What happened

ONEOK reported Q3 2026 net income of $1.35 billion, or $2.13 per diluted share, while adjusted EBITDA rose 6% year-over-year to $2.24 billion. The company raised its full-year financial guidance for the third time this year, citing stronger base-business performance, the contribution from its Brazos Midstream acquisition, and transaction-related benefits. This result aligns with the DeepValue master report's base-case scenario of mid-single-digit annual EBITDA growth through 2027. The sharp increase in net income relative to EBITDA reflects lower tax expense and one-time items, but cash generation remains constrained by elevated capex and a high dividend payout. Overall, the report confirms operational execution but does not yet resolve the balance sheet and free cash flow concerns highlighted in the prior analysis.

Implication

ONEOK's Q3 2026 results validate the base-case growth thesis, with EBITDA growth at the upper end of the 4–6% range and management raising guidance for the third time this year. The market is likely to react positively, but the stock's valuation already incorporates a high dividend yield and modest growth expectations. The primary risk remains elevated leverage (net debt/EBITDA near 4.8x) and near-breakeven free cash flow after dividends and growth capex, which leaves limited margin of safety. Investors should monitor progress toward the 3.5x leverage target and evidence that operating cash flow can self-fund the capex program without additional borrowing. Until those milestones are achieved, the stock may remain range-bound between the $72 entry level and the $90 trim level identified in the master report.

Thesis delta

The Q3 2026 report and guidance raise reinforce the base-case scenario of mid-single-digit EBITDA growth, but they do not introduce new catalysts to shift the thesis from POTENTIAL BUY. The investment case still hinges on deleveraging and a free cash flow inflection, which remain unproven. Consequently, the thesis is unchanged; the stock remains attractive on dips but lacks a clear trigger for re-rating above $90 in the near term.